CNS Pharmaceuticals, Inc. Restricted Cash, Current
CNS Pharmaceuticals, Inc. (CNSP) had Restricted Cash, Current of $0 as of 2020-09-30, per its 10-Q filed 2020-11-12.
Discontinued › Balance Sheet › Assets, Current
us-gaap:RestrictedCashCurrent · last filed 2020-11-12
- 2020-09-30: Restricted Cash, Current $0.00.
- 2020-06-30: Restricted Cash, Current $0.00.
- 2020-03-31: Restricted Cash, Current $0.00.
- 2019-12-31: Restricted Cash, Current $0.00.
| Period end | Restricted Cash, Current |
|---|---|
| 2020-09-30 | $0.00 10-Q · filed 2020-11-12 |
| 2020-06-30 | $0.00 10-Q · filed 2020-08-10 |
| 2020-03-31 | $0.00 10-Q · filed 2020-05-15 |
| 2019-12-31 | $0.00 10-K · filed 2020-03-12 |
| 2019-09-30 | $269.40K 10-Q · filed 2020-11-12 |
| 2019-06-30 | $269.40K 10-Q · filed 2020-08-10 |
| 2019-03-31 | $269.40K 10-Q · filed 2020-05-15 |
| 2018-12-31 | $272.40K 10-K · filed 2020-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |